Skip to main content
. 2014 Feb 26;9(2):e88517. doi: 10.1371/journal.pone.0088517

Figure 10. Model simulations of cypermethrin and DCCA in blood, storage tissues and urine following repeated oral exposure.

Figure 10

Model simulations (lines) of the time courses of cypermethrin in blood (B(t)) (A) and storage tissues (S(t)) (B) as well as trans- and cis-DCCA in urine (U(t); solid and dotted lines, respectively) (C) following a repeated oral exposure, 3 times per day (at 7:30 am, 12: 30 am and 6:30 pm), during 10 consecutive days to a dose corresponding to 1/10 of the dose administered by Woollen et al. (1992) (0.33 mg/day).